- #1
NEILS BOHR
- 79
- 0
Homework Statement
is this compound chiral??why or why not??
http://img827.imageshack.us/i/gmp.png/
Homework Equations
The Attempt at a Solution
i don't think it is...what do u think??
Optical isomerism, also known as chirality, is a phenomenon that occurs in certain compounds where they exist in two mirror-image forms that cannot be superimposed on each other. These two forms are called enantiomers and have identical chemical compositions but differ in their spatial arrangement of atoms. This relates to chirality because chirality is the property of a molecule to have a non-superimposable mirror image, and it is this property that causes optical isomerism in compounds.
GMP, or Good Manufacturing Practices, is a set of guidelines and regulations that ensure the consistency, quality, and safety of pharmaceutical products. In the case of optically active compounds, GMP plays a crucial role in ensuring that the correct enantiomer is produced in the desired quantity and purity. This is important as the two enantiomers of a compound can have different biological effects, and GMP ensures that only the desired enantiomer is present in the final product.
There are various analytical techniques used by scientists to determine the chirality of a compound in GMP. These include polarimetry, chiral chromatography, and nuclear magnetic resonance (NMR) spectroscopy. These techniques allow scientists to analyze the spatial arrangement of atoms in a compound and determine its chirality. This is important in GMP as it ensures the correct enantiomer is produced and meets the required standards.
Yes, optical isomerism can cause issues in drug development and production. If a drug is intended to be a single enantiomer but is produced as a mixture of both enantiomers, it can lead to adverse effects or a lack of desired effects in patients. This is why GMP guidelines are crucial in ensuring the correct enantiomer is produced in pharmaceutical manufacturing.
Yes, there are exceptions to the rule of optical isomerism in GMP. Some compounds may have more than one chiral center and can exist as multiple stereoisomers. In these cases, all the stereoisomers must be produced in the correct proportions to ensure the desired biological effects. Additionally, there are some cases where the two enantiomers of a compound may not have significantly different biological effects, and in these cases, GMP may not require the separation of enantiomers. However, this is determined on a case-by-case basis and must be carefully evaluated by scientists and regulatory bodies.